On Tuesday, Olema Pharmaceuticals Inc (NASDAQ: OLMA) was -2.06% drop from the session before settling in for the closing price of $10.21. A 52-week range for OLMA has been $7.68 – $16.77.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
When this article was written, the company’s average yearly earnings per share was at -8.23%. With a float of $49.58 million, this company’s outstanding shares have now reached $57.29 million.
The firm has a total of 74 workers. Let’s measure their productivity. In terms of profitability, gross margin is 85.67%, operating margin of -7213.69%, and the pretax margin is -6511.62%.
Olema Pharmaceuticals Inc (OLMA) Breakdown of a Key Holders of the stock
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Olema Pharmaceuticals Inc stocks. The insider ownership of Olema Pharmaceuticals Inc is 13.47%, while institutional ownership is 94.09%. The most recent insider transaction that took place on Aug 01 ’24, was worth 35,796,000. In this transaction 10% Owner of this company sold 2,400,000 shares at a rate of $14.91, taking the stock ownership to the 783,118 shares. Before that another transaction happened on Jul 29 ’24, when Company’s Director sold 4,066 for $15.58, making the entire transaction worth $63,348. This insider now owns 752,217 shares in total.
Olema Pharmaceuticals Inc (OLMA) Recent Fiscal highlights
Going through the last 3-months fiscal report unveiled on the 9/30/2024, it has been observed that the corporation posted -0.49 earnings per share (EPS) during the time that was less than consensus figure (set at -0.46) by -0.03. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.59 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -8.23% per share during the next fiscal year.
Olema Pharmaceuticals Inc (NASDAQ: OLMA) Trading Performance Indicators
You can see what Olema Pharmaceuticals Inc (OLMA) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 7.10.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.19, a number that is poised to hit -0.65 in the next quarter and is forecasted to reach -2.63 in one year’s time.
Technical Analysis of Olema Pharmaceuticals Inc (OLMA)
Analysing the last 5-days average volume posted by the [Olema Pharmaceuticals Inc, OLMA], we can find that recorded value of 0.59 million was lower than the volume posted last year of 0.74 million. As of the previous 9 days, the stock’s Stochastic %D was 83.16%. Additionally, its Average True Range was 0.83.
During the past 100 days, Olema Pharmaceuticals Inc’s (OLMA) raw stochastic average was set at 25.99%, which indicates a significant decrease from 46.27% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 99.51% in the past 14 days, which was higher than the 68.58% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $11.24, while its 200-day Moving Average is $11.78. Now, the first resistance to watch is $10.19. This is followed by the second major resistance level at $10.37. The third major resistance level sits at $10.53. If the price goes on to break the first support level at $9.85, it is likely to go to the next support level at $9.69. Now, if the price goes above the second support level, the third support stands at $9.51.
Olema Pharmaceuticals Inc (NASDAQ: OLMA) Key Stats
There are 57,298K outstanding shares of the company, which has a market capitalization of 572.98 million. As of now, sales total 0 K while income totals -96,660 K. Its latest quarter income was 0 K while its last quarter net income were -34,560 K.
